Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Tracon Pharmaceuticals Inc (TCON)

Tracon Pharmaceuticals Inc (TCON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Tracon: Q4 Earnings Snapshot AP - Tue Mar 5, 3:59PM CST

Tracon: Q4 Earnings Snapshot

TCON : 1.8900 (+2.16%)
Tracon: Q3 Earnings Snapshot AP - Thu Nov 9, 2023

Tracon: Q3 Earnings Snapshot

TCON : 1.8900 (+2.16%)
Tracon: Q2 Earnings Snapshot AP - Mon Aug 14, 2023

Tracon: Q2 Earnings Snapshot

TCON : 1.8900 (+2.16%)
Tracon: Q1 Earnings Snapshot AP - Wed May 10, 2023

Tracon: Q1 Earnings Snapshot

TCON : 1.8900 (+2.16%)
Tracon (TCON) Moves to Buy: Rationale Behind the Upgrade Zacks - Tue Mar 14, 2023

Tracon (TCON) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

TCON : 1.8900 (+2.16%)
Tracon: Q4 Earnings Snapshot AP - Wed Mar 8, 2023

Tracon: Q4 Earnings Snapshot

TCON : 1.8900 (+2.16%)
Tracon: Q3 Earnings Snapshot AP - Mon Nov 14, 2022

Tracon: Q3 Earnings Snapshot

TCON : 1.8900 (+2.16%)
US FDA Approval of IND for CTLA-4 Antibody YH001 for the Treatment of Front-line Sarcoma Patients in Combination with Envafolimab Business Wire - Mon Aug 29, 2022

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen") and TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), today jointly announced that the U.S. Food and Drug Administration (FDA) has approved the...

TCON : 1.8900 (+2.16%)
TRACON Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update Globe Newswire - Wed Aug 10, 2022

SAN DIEGO, Aug. 10, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a...

TCON : 1.8900 (+2.16%)
TRACON Pharmaceuticals Announces Results of Independent Data Monitoring Committee Review of Safety Data from ENVASARC Pivotal Trial Globe Newswire - Wed Aug 10, 2022

Trial to Continue as Planned...

TCON : 1.8900 (+2.16%)

Barchart Exclusives

Stocks Plunge Before the Open as Meta’s Revenue Forecast Disappoints, U.S. GDP Data and Earnings in Focus Barchart - 1 hour ago
June S&P 500 E-Mini futures (ESM24) are down -0.53%, and June Nasdaq 100 E-Mini futures (NQM24) are down -0.87% this morning as a disappointing revenue outlook for the current quarter from Meta weighed on sentiment, while market participants braced for a new round of U.S. economic data and quarterly reports from heavyweight names. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot